Literature DB >> 11514558

Early postnatal cardiac changes and premature death in transgenic mice overexpressing a mutant form of serum response factor.

X Zhang1, J Chai, G Azhar, P Sheridan, A M Borras, M C Furr, K Khrapko, J Lawitts, R P Misra, J Y Wei.   

Abstract

Serum response factor (SRF) is a key regulator of a number of extracellular signal-regulated genes important for cell growth and differentiation. A form of the SRF gene with a double mutation (dmSRF) was generated. This mutation reduced the binding activity of SRF protein to the serum response element and reduced the capability of SRF to activate the atrial natriuretic factor promoter that contains the serum response element. Cardiac-specific overexpression of dmSRF attenuated the total SRF binding activity and resulted in remarkable morphologic changes in the heart of the transgenic mice. These mice had dilated atrial and ventricular chambers, and their ventricular wall thicknesses were only 1/2 to 1/3 the thickness of that of nontransgenic mice. Also these mice had smaller cardiac myocytes and had less myofibrils in their myocytes relative to nontransgenic mice. Altered gene expression and slight interstitial fibrosis were observed in the myocardium of the transgenic mice. All the transgenic mice died within the first 12 days after birth, because of the early onset of severe, dilated cardiomyopathy. These results indicate that dmSRF overexpression in the heart apparently alters cardiac gene expression and blocks normal postnatal cardiac growth and development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514558     DOI: 10.1074/jbc.M104934200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Serum response factor: look into the gut.

Authors:  Cristina Modak; Jianyuan Chai
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Cardiac expression of ms1/STARS, a novel gene involved in cardiac development and disease, is regulated by GATA4.

Authors:  Samir Ounzain; Satoru Kobayashi; Richard E Peterson; Aibin He; Anna Motterle; Nilesh J Samani; Donald R Menick; William T Pu; Qiangrong Liang; Nelson W Chong
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

3.  Partnering up for cardiac hypertrophy.

Authors:  John P Konhilas; Leslie A Leinwand
Journal:  Circ Res       Date:  2006-04-28       Impact factor: 17.367

Review 4.  Re-employment of developmental transcription factors in adult heart disease.

Authors:  Toru Oka; Jian Xu; Jeffery D Molkentin
Journal:  Semin Cell Dev Biol       Date:  2006-11-24       Impact factor: 7.727

Review 5.  The STARS signaling pathway: a key regulator of skeletal muscle function.

Authors:  Séverine Lamon; Marita A Wallace; Aaron P Russell
Journal:  Pflugers Arch       Date:  2014-02-21       Impact factor: 3.657

6.  A critical role of serum response factor in myofibroblast differentiation during experimental oesophageal ulcer healing in rats.

Authors:  Jianyuan Chai; Manith Norng; Andrzej S Tarnawski; Justine Chow
Journal:  Gut       Date:  2006-10-26       Impact factor: 23.059

7.  Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2.

Authors:  Yasuhiko Sakata; Caramai N Kamei; Hironori Nakagami; Roderick Bronson; James K Liao; Michael T Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-26       Impact factor: 11.205

8.  Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop.

Authors:  Hyun Kook; John J Lepore; Aaron D Gitler; Min Min Lu; Wendy Wing-Man Yung; Joel Mackay; Rong Zhou; Victor Ferrari; Peter Gruber; Jonathan A Epstein
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

9.  MURC, a muscle-restricted coiled-coil protein that modulates the Rho/ROCK pathway, induces cardiac dysfunction and conduction disturbance.

Authors:  Takehiro Ogata; Tomomi Ueyama; Koji Isodono; Masashi Tagawa; Naofumi Takehara; Tsuneaki Kawashima; Koichiro Harada; Tomosaburo Takahashi; Tetsuo Shioi; Hiroaki Matsubara; Hidemasa Oh
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

10.  Myocardin mRNA is augmented in the failing myocardium: expression profiling in the porcine model and human dilated cardiomyopathy.

Authors:  Mario Torrado; Eduardo López; Alberto Centeno; Constancio Medrano; Alfonso Castro-Beiras; Alexander T Mikhailov
Journal:  J Mol Med (Berl)       Date:  2003-08-13       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.